Antenatal exposure to atenolol and retroperitoneal fibromatosis

Reproductive Toxicology

Volumn 11, Issue 4, 1997, Pages 539-541

  Satgé, Daniel ^a   Sasco, Annie J ^b   Col, Jean Yves ^c   Lemonnier, Patrick G ^e   Hemet, Jacques ^e   Robert, Elisabeth ^d  

^a CENTRE HOSPITALIER   (France)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c LE HAVRE HOSPITAL   (France)

^d Institut Europeen des Genomutations   (France)

^e NONE

Author keywords

blockers; Antihypertensives; Atenolol; Fibrosis; Newborn; Pregnancy; Retroperitoneal fibromatosis; Transplacental carcinogenesis

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; DACTINOMYCIN; MAGNESIUM; METOCLOPRAMIDE; TENORMINE; UNCLASSIFIED DRUG; VINCRISTINE;

ADULT; ARTICLE; CASE REPORT; DRUG EFFECT; ECHOGRAPHY; FEMALE; FETUS; FIBROMA; HUMAN; HYPERTENSION; IATROGENIC DISEASE; MALE; OBESITY; ORAL DRUG ADMINISTRATION; PREGNANCY; PRENATAL DRUG EXPOSURE; RETROPERITONEAL FIBROSIS; RETROPERITONEAL TUMOR; SCOLIOSIS; TRANSPLACENTAL CARCINOGENESIS;

ADULT; ANTIHYPERTENSIVE AGENTS; ATENOLOL; FEMALE; FETUS; FIBROMA; HUMANS; MALE; PREGNANCY; RETROPERITONEAL NEOPLASMS;

EID: 0031195316     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0890-6238(97)00021-X     Document Type: Article

References (19)

1. 1. Isaacs H. Tumors of the newborn and infant. St Louis, MO: Mosby Year Book; 1991:170-227.
2. 2. Col J-Y, Vannier J-P, Chabrolle J-P, Brottier C. Fibromatose à révélation échographique anténatale. J Gynecol Obstet Biol Reprod. 1995;24:52-6.
3. 3. Doherty CC, McGeown MG, Donaldson RA. Retroperitoneal fibrosis after treatment with atenolol. Br Med J. 1978;2:1786.
4. 4. Johnson JN, McFarland J. Retroperitoneal fibrosis associated with atenolol. Br Med J. 1980;1:864.
5. 5. Idänpään-Heikkilä JE, Hästbacka J, Järvinen HJJ. Eye and skin reactions precede practolol peritonitis. Lancet. 1977;2:1354.
6. 6. Bullimore DW. Retroperitoneal fibrosis associated with atenolol. Br Med J. 1980;2:564.
7. 7. Proulx S, Schneiweiss F. β-blocker-induced retroperitoneal fibrosis. Drug Intell Clin Pharm. 1985;19:359-60.
8. 8. Zanavella T, Radaelli G, Girotti P, Arias E, Ameri L, Presta M, Mazzoleni G, Ragnotti G. Evaluation of the tumor-promoting activity of two β-adrenoreceptor blocking agents, propranolol and atenolol, in liver of Fisher 344 rats. Carcinogenesis. 1994;15: 2531-9.
9. 9. Case records of the Massachussetts General Hospital. Case 27-1996. N Engl J Med. 1996;335:650-5.
10. 10. Clark SK, Phillips RKS. Desmoids in familial adenomatous polyposis. Br J Surg. 1996;83:1494-504.
11. 11. Reynolds B, Butters L, Evans J, Adams T, Rubin PC. First year of life after the use of atenolol in pregnancy associated hypertension. Arch Dis Child. 1984;59:1061-3.
12. 12. Lardoux H, Gerard J, Blazquez G, Chouty F, Flouvat B. Hypertension in pregnancy: evaluation of two β blockers atenolol and labetalol. Eur Heart J. 1983;4(Suppl G):35-40.
13. 13. Rubin PC, Butters L, Clark DM, Reynolds B, Sumner DJ, Steedman D, Low RA, Reid JL. Placebo-controlled trial of atenolol in treatment of pregnancy-associated hypertension. Lancet. 1983; 1:431-4.
14. 14. Dubois D, Petitcolas J, Temperville B, Klepper A, Catherine P. Treatment of hypertension in pregnancy with β-adrenergic antagonists. Br J Clin Pharmacol Suppl. 1982;13:375S-8S.
15. 15. Butters L, Kennedy S, Rubin PC. Atenolol in essential hypertension during pregnancy. Br Med J. 1990;301:587-9.
16. 16. Thorley KJ, Mcainsh J, Cruickshank JM. Atenolol in the treatment of pregnancy-induced hypertension. Br J Clin Pharmacol. 1981; 12:725-30.
17. 17. Rice JM, Rehm S, Donovan PJ, Perantoni AO. Comparative transplacental carcinogenesis by directly acting and metabolism-dependent alkylating agents in rodents and non human primates. In: Napalkov MP, Rice JM, Tomatis L, Yamasaki H, eds. Perinatal and multigeneration carcinogenesis. Lyon: IARC; 1989.
18. 18. Ehrenbard LT, Chaganti RSK. Cancer in the fetal hydantoin syndrome. Lancet. 1981;2:97.
19. 19. Melnick S, Cole P, Anderson D, Herbst A. Rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: an update. N Engl J Med.1987;316:514-6.